Choosing the Right Electronic Lab Notebook

Tips for evaluating and implementing the right electronic lab notebook (ELN)

Written byTanuja Koppal, PhD
| 7 min read
Register for free to listen to this article
Listen with Speechify
0:00
7:00

Contributing editor Tanuja Koppal, PhD, talks to two chemists, who are both users of electronic lab notebooks (ELNs), about their experiences and what they’ve learned. They discuss the reasons behind transitioning from a paper notebook to an ELN, what factors they considered important to have in an ELN, how they went about choosing the right vendor, and how they implemented the ELN to suit their needs.

M. Emilia Di Francesco obtained her master’s degree in chemistry from the University of Rome La Sapienza, and soon after joined the Merck Research Laboratories, working as a medicinal chemist in both their Italian and UK research sites. After a few years, she moved to Cambridge, UK, for her PhD studies, and then returned to Merck (Rome, Italy, and Boston, Massachusetts, USA), where she led medicinal chemistry projects in several different therapeutic areas, including antiviral and oncology. In 2012, she joined the MD Anderson Cancer Center, Houston, Texas, USA, as the group leader for the medicinal chemistry team in the newly founded Institute for Applied Cancer Science (IACS). Together with the team at IACS, she is focusing on metabolism and epigenetic targets and leveraging the clinical and basic research expertise at MD Anderson, with the goal of developing novel therapies for cancer patients.

Excerpts from an interview with M. Emilia Di Francesco, PhD, group leader for Medicinal Chemistry at the Institute for Applied Cancer Science (IACS) at MD Anderson Cancer Center

Q: As a medicinal chemist, why do you need ELNs for your work?

A: Currently we use ELNs to track the experimental procedures used for chemical synthesis as well as for analytical characterization of the quality and purity of the end product. I first came in contact with ELNs while working at Merck, and like many big pharma, they transitioned to using ELNs many years ago for all the advantages it offered. So when it was time to move out of big pharma, I wanted to invest in and implement ELNs in the lab, although I was moving into an organization with a much smaller operation.

Q: Can you mention some of the advantages that ELNs offer you?

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

About the Author

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image